Dengming Xiao

This inventor holds 28 USPTO granted patents and 18 published patent applications, plus 8 CIPO patents and 12 EPO patents, primarily in AKT Protein Kinase Inhibitors. Top assignees: Array Biopharma Inc., Genentech, Inc., Cv Therapeutics, Inc.. Active years: 2003-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dengming Xiao. Retrieved from https://idiyas.com/inventor/dengming-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 18)

% Patents Active = 53.6

CIPO Patents = 8

EPO Patents = 12 (Patent Applications = 7)

Average Co-Inventor Count = 7.3

ph-index = 10

Forward Citations = 291(Granted Patents)

Location History:

Longmont, CO (US) (2003 - 2016)
Boulder, CO (US) (2014 - 2016)

Company Filing History:

Cv Therapeutics, Inc.

patents

4. 2 out of 15

Gilead Palo Alto, Inc.

patents

5. 2 out of 1,342

The Penn State Research Foundation

Gilead Sciences, Inc.

patents

9. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2016

Loading Chart...

Areas of Expertise:

Pyrimidyl Cyclopentanes

AKT Inhibitors

Hydroxylated Compounds

Methoxylated Compounds

Piperazines

A2B Adenosine Receptor Antagonists

Chiral Ligands

Transition-Metal Complexes

Asymmetric Reactions

Dihydrofuro Pyrimidines

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2016-08-09),

2. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2016-06-07),

3. 9303040 - Substituted piperazines as AKT inhibitors (2016-04-05),

4. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor (2014-10-07),

5. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-10-07),

6. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2014-09-30),

7. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-09-30),

8. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors (2014-09-16),

9. 8680114 - AKT protein kinase inhibitors (2014-03-25),

10. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-12-31),

11. 8377937 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-02-19),

12. 8329701 - Dihydrofuro pyrimidines as AKT protein kinase inhibitors (2012-12-11),

13. 8324224 - [object Object] (2012-12-04),

14. 8063050 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2011-11-22),

15. 8003651 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2011-08-23),

Title: The Innovative Journey of Dengming Xiao

Introduction: Dengming Xiao, a talented inventor based in Longmont, CO, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Dengming Xiao holds several patents in various technological areas, including artificial intelligence, renewable energy, and advanced materials.

Career Highlights: With a background in engineering and a passion for innovation, Dengming Xiao has successfully developed cutting-edge solutions that have revolutionized industries. His work has been recognized for its creativity and practicality.

Collaborations: Throughout his career, Dengming Xiao has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions and bring them to the market. His collaborative spirit has led to the successful implementation of his ideas in real-world applications.

Conclusion: Dengming Xiao's dedication to innovation and his relentless pursuit of technological advancement make him a standout figure in the world of inventors. His contributions continue to inspire future generations of inventors and shape the landscape of technology.

Profile summary based on public USPTO records.